• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Post-Approval Studies (PAS) Database

  • Print
  • Share
  • E-mail
-

The FDA has the authority to require sponsors to perform a post-approval study (or studies) at the time of approval of a premarket approval (PMA), humanitarian device exemption (HDE), or product development protocol (PDP) application. Post-approval studies can provide patients, health care professionals, the device industry, the FDA and other stakeholders information on the continued safety and effectiveness (or continued probable benefit, in the case of an HDE) of approved medical devices. This database allows you to search Post-Approval Study information by applicant or device information.

Learn more...


           

AED 3 and Pad Placement PAS


Suggest Enhancement / Report Issue | export reports to excelExport to Excel
General
Study Status Delayed
Application Number /
Requirement Number
P160015 S001/ PAS001
Date Original Protocol Accepted 06/05/2020
Date Current Protocol Accepted 07/16/2026
Study Name AED 3 and Pad Placement PAS
Device Name AED 3 defibrillator
General Study Protocol Parameters
Study Design Other Study Design
Data Source New Data Collection
Comparison Group No Control
Analysis Type Descriptive
Study Population Adolescent: 13-18 yrs, Adult: At least 22 yrs
Detailed Study Protocol Parameters
Study Objectives This is a prospective, observational study.
Enrollment in this study is expected to take approximately 36 months. The full study timeline is below. Subjects are enrolled once EMS personnel are on-scene and able to make an assessment of outcome measures listed below. No data will be collected about CPR quality or patient outcomes. Subjects will not be followed after the assessment of study objectives.
The objectives of the study are:
• Demonstrate appropriate CPR sensor placement on pediatric and adult patients
• Demonstrate delivery of appropriate energy level shocks to pediatric and adult patients
Additionally, a limited human factors study will be conducted using manikins. Participants will be randomly assigned to either the ‘adult scenario’ or the ‘pediatric scenario’.
Study Population Candidates for this study must meet all of the following Inclusion criteria:
1. Suspected out-of-hospital cardiac arrest
2. Use of ZOLL AED 3 PAD (running software v. 1.03.602 or newer (US) or v. 6.03.006 or newer (International)) with Uni-padz III
3. Unconsciousness
4. Absence of breathing
5. Absence of pulse and other signs of circulation
The limited human factors study will be conducted using adult and pediatric manikins.
Sample Size Approximately 73 adult subjects and 15 pediatric subjects were planned to be enrolled in this study. Only 38 adult subjects have been enrolled so far.
There are currently two sites:
1. The University at Buffalo (UB), initiated on March 30, 2021.
2. Colonie EMS (New York) initiated on December 19th, 2022.
The human factors study will be conducted in 32 lay rescuers and 32 professional users.
Key Study Endpoints Study endpoints include appropriate placement of the electrodes which will be assessed by EMS personnel based on observations made when they arrive on scene, the appropriate selection of adult or pediatric mode which will be assessed by identifying that the child button was pressed when the estimated age is less than 8 years old, and the delivery of defibrillation energy which will be determined by documented whether the energy was age-appropriate if a shock was delivered.
Endpoints assessed for the human factors study are:
- The appropriate placement of the CPR sensor
- The appropriate selection of adult or pediatric mode
Follow-up Visits and Length of Follow-up Subjects will not be followed after the assessment of study objectives
Interim or Final Data Summary
Interim Results Safety Results
Pads placed appropriately based on age: Yes (38), No (0)
Patient mode appropriately selected: Yes (37), No (0), Unkown (1)
Note: Pads were placed on participant 477011-004 but EMS arrived and removed AED before the device completed the startup process. This is the unknown subject.

Effectiveness Results
Appropriate shock energy delivered: Yes (8), No (0), No Shocks (29), Unkown (1)
Note: Unknown is for the same reason as above.
Actual Number of Patients Enrolled 38
Actual Number of Sites Enrolled Two study sties enrolled:
1) University of Buffalo (Buffalo, NY)
2) Colonie EMS (New York, NY)
Patient Follow-up Rate N/A


AED 3 and Pad Placement PAS Reporting Schedule

Reporting Schedule
Report
Date Due
FDA Receipt
Date
Applicant's Reporting Status
6 month report 08/28/2020 08/21/2020 On Time
1 year report 02/27/2021 03/01/2021 Overdue/Received
18 month report 08/28/2021 08/25/2021 On Time
2 year report 02/27/2022 02/25/2022 On Time
3 year report 02/27/2023 02/27/2023 On Time
4 year report 02/27/2024 02/14/2024 On Time
54 month report 08/27/2024 08/22/2024 On Time
5 year report 02/27/2026 02/27/2026 On Time
final report 06/27/2027    


Contact Us

Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources

-
-